Arrowhead Pharmaceuticals Ownership | Who Owns Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals Ownership Summary
Arrowhead Pharmaceuticals is owned by 79.29% institutional investors, 4.47% insiders, and 16.24% retail investors. Blackrock is the largest institutional shareholder, holding 12.72% of ARWR shares. iShares Core S&P Mid-Cap ETF is the top mutual fund, with 3.15% of its assets in Arrowhead Pharmaceuticals shares.
ARWR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Arrowhead Pharmaceuticals | 79.29% | 4.47% | 16.24% |
| Sector | Healthcare Stocks | 47.38% | 7.99% | 44.63% |
| Industry | Biotech Stocks | 45.43% | 7.81% | 46.75% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 15.68M | 12.72% | $407.61M |
| Vanguard group | 12.21M | 9.91% | $317.44M |
| Avoro capital advisors | 8.89M | 7.21% | $231.02M |
| Fmr | 6.81M | 5.53% | $177.05M |
| State street | 5.84M | 4.74% | $151.72M |
| Slate path capital lp | 4.14M | 3.36% | $107.57M |
| Geode capital management | 2.94M | 2.38% | $76.37M |
| T. rowe price investment management | 2.56M | 2.08% | $66.56M |
| Jpmorgan chase | 2.32M | 1.88% | $60.19M |
| Ubs asset management americas | 2.29M | 1.86% | $59.52M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Aquilo capital management | 908.47K | 22.76% | $23.61M |
| Western financial corp/ca | 820.24K | 12.88% | $21.32M |
| Avoro capital advisors | 8.89M | 3.08% | $231.02M |
| M28 capital management lp | 67.40K | 2.27% | $1.75M |
| Slate path capital lp | 4.14M | 2.05% | $107.57M |
| Privium fund management b.v. | 286.94K | 1.85% | $7.24M |
| Johnson & johnson | 247.60K | 1.61% | $6.44M |
| Wealth effects | 159.60K | 1.50% | $4.15M |
| Hound partners | 269.93K | 1.41% | $7.02M |
| Artal group | 1.00M | 0.66% | $25.99M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Norges bank | 1.59M | 0.01% | 1.59M |
| Ubs asset management americas | 2.29M | 0.02% | 1.36M |
| T. rowe price investment management | 2.56M | 0.04% | 801.95K |
| Morgan stanley | 1.82M | 0.00% | 679.41K |
| Jane street group | 696.72K | 0.00% | 568.65K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rokos capital management llp | - | - | -939.98K |
| Orbimed advisors | - | - | -739.65K |
| State street | 5.84M | 0.01% | -722.94K |
| E. ohman j:or asset management ab | - | - | -714.21K |
| Pictet asset management sa | 743.68K | 0.02% | -482.30K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 1.59M | 0.01% | 1.59M | $41.20M |
| Squarepoint ops | 383.83K | 0.02% | 383.83K | $9.98M |
| Hound partners | 269.93K | 1.41% | 269.93K | $7.02M |
| Abrdn | 248.67K | 0.01% | 248.67K | $6.46M |
| Mirae asset global etfs | 231.54K | 0.01% | 231.54K | $6.02M |
Sold Out
| Holder | Change |
|---|---|
| Toronto dominion bank | -3.00 |
| Financial gravity asset management | -4.00 |
| Advisornet financial | -7.00 |
| Innealta capital | -11.00 |
| Riggs asset managment | -14.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 282 | -1.40% | 97,756,300 | 2.92% | 79 | 1.34% | 135 | -7.53% | 82 | 7.89% |
| Mar 31, 2024 | 286 | 1.06% | 94,985,786 | 22.73% | 77 | 1.48% | 146 | 18.70% | 76 | -19.15% |
| Dec 31, 2023 | 283 | 9.69% | 77,395,477 | 5.41% | 72 | 1.54% | 123 | 7.89% | 94 | - |
| Sep 30, 2023 | 258 | -9.15% | 73,421,452 | 1.59% | 68 | 1.50% | 114 | -4.20% | 94 | -14.55% |
| Jun 30, 2023 | 284 | 6.37% | 72,271,971 | -0.95% | 67 | 1.45% | 119 | 0.85% | 110 | 17.02% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 3.92M | 3.15% | 2.13K |
| Vanguard Total Stock Mkt Idx Inv | 3.70M | 2.98% | 3.98K |
| iShares Russell 2000 ETF | 3.07M | 2.47% | -6.90K |
| Vanguard Small Cap Index | 2.95M | 2.38% | -34.57K |
| SPDR® S&P Biotech ETF | 1.96M | 1.58% | 21.71K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.89M | 1.52% | 8.20K |
| Vanguard Small Cap Growth Index Inv | 1.63M | 1.31% | -19.93K |
| Fidelity Growth Compy Commingled Pl S | 1.29M | 1.04% | 80.27K |
| Fidelity Small Cap Index | 1.22M | 0.98% | -30.23K |
| Fidelity Growth Compy Commingled Pl O | 1.21M | 0.98% | 127.90K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 02, 2024 | Oliver Tracie | Chief Commercial Officer | Sell | $237.48K |
| May 02, 2024 | Vakiener Victoria | - | Sell | $41.93K |
| Apr 01, 2024 | Hamilton James C | Chief Discovery/Trans Medicine | Sell | $168.18K |
| Mar 20, 2024 | Lu Hongbo | - | Buy | $27.50K |
| Mar 19, 2024 | Lu Hongbo | - | Buy | $28.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | - | 1 |
| 2024 Q2 | - | 2 |
| 2024 Q1 | 3 | 37 |
| 2023 Q4 | - | 4 |
| 2023 Q3 | - | 4 |
ARWR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools